Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Alison Oliveto

Concepts (177)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cocaine-Related Disorders
21
2025
209
4.240
Why?
Opioid-Related Disorders
21
2025
393
4.220
Why?
Methadone
16
2025
183
3.180
Why?
Disulfiram
3
2025
13
1.750
Why?
Alcohol Deterrents
2
2025
11
1.390
Why?
Sertraline
3
2017
46
1.380
Why?
Naloxone
5
2013
81
1.320
Why?
Narcotic Antagonists
9
2013
136
1.250
Why?
Buprenorphine
10
2023
145
1.140
Why?
Substance Withdrawal Syndrome
6
2021
168
1.090
Why?
Opiate Substitution Treatment
5
2025
99
1.080
Why?
Narcotics
11
2025
112
1.080
Why?
Double-Blind Method
21
2025
708
1.070
Why?
Analgesics, Opioid
7
2023
575
0.980
Why?
Cyclohexanecarboxylic Acids
3
2014
20
0.940
Why?
Amines
3
2014
41
0.940
Why?
gamma-Aminobutyric Acid
3
2014
65
0.920
Why?
Methadyl Acetate
3
2010
11
0.900
Why?
Amphetamine-Related Disorders
3
2021
93
0.820
Why?
Adult
36
2025
13577
0.800
Why?
Dose-Response Relationship, Drug
11
2025
1372
0.790
Why?
Video Games
1
2022
13
0.780
Why?
Methamphetamine
3
2021
194
0.760
Why?
Cocaine
7
2025
182
0.720
Why?
Prescription Drug Misuse
1
2019
34
0.630
Why?
Drug Monitoring
1
2019
79
0.630
Why?
Middle Aged
22
2025
12611
0.590
Why?
Depression
2
2014
582
0.580
Why?
Male
34
2025
25907
0.580
Why?
Dopamine Uptake Inhibitors
3
2007
59
0.570
Why?
Female
33
2025
27081
0.550
Why?
Databases, Factual
1
2019
673
0.510
Why?
Remote Consultation
1
2015
28
0.500
Why?
Humans
46
2025
50503
0.500
Why?
Neurology
1
2015
42
0.490
Why?
Desipramine
6
2005
26
0.470
Why?
Isradipine
2
2004
5
0.450
Why?
Rural Health Services
1
2015
169
0.430
Why?
Diltiazem
1
2013
10
0.430
Why?
Excitatory Amino Acid Antagonists
1
2013
51
0.420
Why?
Verapamil
1
2013
22
0.420
Why?
Emergency Service, Hospital
4
2021
484
0.420
Why?
Calcium Channel Blockers
1
2013
62
0.410
Why?
Electrocardiography
1
2013
266
0.370
Why?
Behavior Therapy
2
2010
185
0.350
Why?
Sodium Oxybate
1
2010
11
0.350
Why?
Pilot Projects
8
2021
698
0.350
Why?
Behavior
1
2010
47
0.350
Why?
Bupropion
2
2007
34
0.340
Why?
Hypnotics and Sedatives
1
2010
74
0.330
Why?
Combined Modality Therapy
5
2017
641
0.320
Why?
Benzhydryl Compounds
1
2009
64
0.320
Why?
Treatment Outcome
10
2025
5283
0.300
Why?
Citalopram
1
2007
18
0.280
Why?
Drug Therapy, Combination
5
2014
384
0.280
Why?
Feedback
2
2023
53
0.240
Why?
Adrenergic Uptake Inhibitors
1
2005
15
0.240
Why?
Stress Disorders, Post-Traumatic
1
2010
383
0.240
Why?
Dextromethorphan
1
2004
16
0.230
Why?
Antidepressive Agents, Tricyclic
5
2004
27
0.220
Why?
Discrimination Learning
1
2004
64
0.220
Why?
Cycloserine
1
2003
3
0.220
Why?
Antimetabolites
1
2003
12
0.220
Why?
Behavior Control
1
2003
3
0.220
Why?
Diagnosis, Dual (Psychiatry)
3
2014
41
0.210
Why?
Tai Ji
1
2023
22
0.210
Why?
Naltrexone
1
2003
59
0.210
Why?
Behavior, Addictive
1
2003
58
0.210
Why?
Secondary Prevention
2
2013
79
0.200
Why?
Young Adult
5
2021
4102
0.200
Why?
Nalbuphine
1
2002
2
0.200
Why?
Butorphanol
1
2002
6
0.200
Why?
Dextroamphetamine
1
2021
39
0.190
Why?
Emotions
1
2023
168
0.190
Why?
Prospective Studies
3
2019
2378
0.190
Why?
Heroin Dependence
4
2006
44
0.180
Why?
Placebos
4
2011
87
0.180
Why?
GABA Agonists
2
2014
14
0.180
Why?
Predictive Value of Tests
2
2019
930
0.180
Why?
Patient Compliance
2
2014
233
0.180
Why?
Self Report
2
2013
206
0.170
Why?
Chromatography, High Pressure Liquid
1
2021
326
0.170
Why?
Guideline Adherence
1
2021
136
0.170
Why?
Adolescent
3
2022
6443
0.170
Why?
Psychomotor Agitation
1
2020
51
0.170
Why?
Tandem Mass Spectrometry
1
2021
238
0.170
Why?
Blood Pressure
3
2011
531
0.170
Why?
Central Nervous System Stimulants
1
2021
209
0.160
Why?
Severity of Illness Index
2
2013
978
0.160
Why?
Retrospective Studies
4
2022
6263
0.150
Why?
Antipsychotic Agents
1
2020
233
0.150
Why?
Ambulatory Care
3
2011
230
0.150
Why?
Risk Assessment
2
2020
1270
0.150
Why?
Effect Modifier, Epidemiologic
1
2017
7
0.150
Why?
Pain Management
1
2019
180
0.140
Why?
Area Under Curve
2
2010
179
0.140
Why?
Analysis of Variance
5
2004
552
0.130
Why?
Chronic Pain
1
2019
182
0.130
Why?
Heart Rate
2
2011
307
0.130
Why?
Mass Screening
1
2019
344
0.130
Why?
Transportation
1
2015
28
0.130
Why?
Psychiatric Status Rating Scales
4
2011
318
0.130
Why?
Time Factors
3
2011
2935
0.130
Why?
Travel
1
2015
36
0.130
Why?
Nipecotic Acids
2
2006
2
0.120
Why?
Diagnostic and Statistical Manual of Mental Disorders
2
2013
74
0.120
Why?
Tissue Plasminogen Activator
1
2015
110
0.120
Why?
Anxiety
2
2022
285
0.120
Why?
Cognition
2
2023
346
0.120
Why?
Recurrence
2
2014
659
0.110
Why?
Directly Observed Therapy
1
2013
7
0.110
Why?
Maintenance Chemotherapy
1
2013
48
0.110
Why?
Socioeconomic Factors
1
2015
591
0.110
Why?
Patient Dropouts
1
2013
52
0.110
Why?
Induction Chemotherapy
1
2013
59
0.110
Why?
Calcium Channels, L-Type
1
2013
68
0.100
Why?
Medication Adherence
1
2014
129
0.100
Why?
Drug Interactions
1
2013
206
0.100
Why?
Depressive Disorder, Major
2
2004
151
0.100
Why?
Injections, Intramuscular
2
2020
48
0.100
Why?
Substance Abuse Treatment Centers
1
2011
79
0.090
Why?
Confusion
1
2010
20
0.090
Why?
Affect
1
2011
103
0.090
Why?
Kaplan-Meier Estimate
1
2011
464
0.090
Why?
Respiration
1
2010
99
0.080
Why?
Arkansas
1
2015
1985
0.080
Why?
Psychomotor Performance
1
2010
130
0.080
Why?
Sleep
1
2011
181
0.080
Why?
Hemodynamics
1
2010
265
0.080
Why?
Alcohol Drinking
1
2010
227
0.080
Why?
Connecticut
2
2005
16
0.080
Why?
Progestins
1
2007
11
0.070
Why?
Progesterone
1
2007
57
0.070
Why?
Substance Abuse Detection
2
2006
90
0.070
Why?
Sex Characteristics
1
2008
198
0.070
Why?
Anti-Anxiety Agents
1
2006
34
0.070
Why?
Anxiety Disorders
1
2007
123
0.070
Why?
Cues
1
2006
51
0.060
Why?
Urinalysis
1
2005
33
0.060
Why?
Depressive Disorder
1
2007
335
0.060
Why?
Linear Models
2
2021
279
0.060
Why?
GABA Agents
1
2003
3
0.060
Why?
Token Economy
1
2003
33
0.050
Why?
Prefrontal Cortex
1
2023
86
0.050
Why?
Prognosis
2
2005
1978
0.050
Why?
Tobacco Use Disorder
1
2004
171
0.050
Why?
Ketoconazole
1
2002
10
0.050
Why?
Pain Measurement
1
2003
270
0.050
Why?
Limit of Detection
1
2021
16
0.050
Why?
Reproducibility of Results
2
2021
1197
0.050
Why?
Outpatients
1
2022
117
0.050
Why?
Controlled Clinical Trials as Topic
1
2020
22
0.040
Why?
Pain
1
2023
387
0.040
Why?
Magnetic Resonance Imaging
2
2023
1548
0.040
Why?
Clinical Trials as Topic
1
2002
486
0.040
Why?
California
1
2019
86
0.040
Why?
Ambulatory Care Facilities
1
2019
120
0.040
Why?
Practice Guidelines as Topic
1
2021
468
0.040
Why?
Brain
1
2006
1319
0.040
Why?
Randomized Controlled Trials as Topic
1
2020
573
0.040
Why?
Drug Administration Schedule
2
2006
370
0.030
Why?
Adrenergic alpha-2 Receptor Agonists
2
2004
9
0.030
Why?
Aged
3
2019
9741
0.030
Why?
Comorbidity
2
2006
623
0.030
Why?
Echo-Planar Imaging
1
2006
11
0.020
Why?
Photic Stimulation
1
2006
55
0.020
Why?
Reward
1
2006
115
0.020
Why?
Interview, Psychological
1
2004
22
0.010
Why?
Cerebral Cortex
1
2006
197
0.010
Why?
Receptors, Opioid, mu
1
2004
46
0.010
Why?
Psychometrics
1
2004
232
0.010
Why?
Oxygen
1
2006
321
0.010
Why?
Receptors, Opioid
1
2002
18
0.010
Why?
Chi-Square Distribution
1
2002
277
0.010
Why?
Cross-Over Studies
1
2002
228
0.010
Why?
Proportional Hazards Models
1
2002
415
0.010
Why?
Antifungal Agents
1
2002
331
0.010
Why?
Oliveto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description